
Meridian Bioscience VIVO
Quarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience ROA Ratio 2011-2026 | VIVO
Annual ROA Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.17 | 15.88 | 11.4 | 7.49 | 9.49 | 8.63 | 12.8 | 19.39 | 19.64 | 21.52 | 20.68 | 17.26 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.52 | 7.49 | 14.44 |
Quarterly ROA Ratio Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.66 | 15.53 | 12.05 | 14.66 | 14.42 | 14.78 | 16.38 | 20.56 | 21.31 | 15.83 | 15.49 | 10.26 | 4.53 | 6.93 | 7.83 | 8.99 | 11.35 | 10.6 | 10.73 | 8.11 | 7.41 | 7.42 | 7.31 | 10.69 | 10.66 | 12.92 | 15.36 | 16.85 | 19.21 | 18.89 | 18.9 | 18.92 | 18.54 | 18.33 | 18.88 | 19.64 | 20.97 | 22.11 | 22.25 | 21.82 | 21.28 | 20.13 | 19.13 | 18.2 | 17.18 | 4.32 | 4.4 | 4.23 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.25 | 4.23 | 14.21 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 17.65 | 3.67 % | $ 186 M | ||
|
Agilent Technologies
A
|
11.3 | $ 118.75 | 1.04 % | $ 36.1 B | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-5.17 | $ 20.84 | 0.68 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-189.54 | $ 1.59 | - | $ 2.12 M | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 24.63 | 0.11 % | $ 684 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 186.62 | 0.66 % | $ 9.25 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 430.03 | -0.07 % | $ 12.4 B | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 15.12 | 1.44 % | $ 457 M | ||
|
Myriad Genetics
MYGN
|
-51.78 | $ 3.97 | -21.17 % | $ 368 M | ||
|
NeoGenomics
NEO
|
-7.94 | $ 8.7 | -1.81 % | $ 1.11 B | ||
|
National Research Corporation
NRC
|
8.6 | $ 18.29 | -2.4 % | $ 409 M | ||
|
Natera
NTRA
|
-39.28 | $ 215.11 | 4.03 % | $ 21.2 B | ||
|
Guardant Health
GH
|
-20.67 | $ 90.73 | 1.35 % | $ 11.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.06 | 2.31 % | $ 20 B | ||
|
Personalis
PSNL
|
-30.08 | $ 5.96 | 7.1 % | $ 353 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 123.29 | 1.62 % | $ 10.2 B | ||
|
Illumina
ILMN
|
-19.4 | $ 141.08 | 1.45 % | $ 22.4 B | ||
|
Senseonics Holdings
SENS
|
-54.73 | $ 5.1 | 2.0 % | $ 213 M | ||
|
Soleno Therapeutics
SLNO
|
3.71 | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
Interpace Biosciences
IDXG
|
72.63 | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.15 | -1.49 % | $ 4.94 M | ||
|
Lantheus Holdings
LNTH
|
10.49 | $ 86.12 | 0.35 % | $ 5.81 B | ||
|
Thermo Fisher Scientific
TMO
|
6.08 | $ 473.2 | 1.38 % | $ 178 B | ||
|
Trinity Biotech plc
TRIB
|
0.78 | $ 0.6 | 0.45 % | $ 61.9 M | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 258.91 | 0.69 % | $ 21.5 B | ||
|
Twist Bioscience Corporation
TWST
|
-12.1 | $ 60.0 | 5.82 % | $ 3.59 B | ||
|
Celcuity
CELC
|
-37.95 | $ 141.31 | -0.27 % | $ 6.61 B | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 9.29 | 0.22 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 191.25 | 0.21 % | $ 21.2 B | ||
|
Waters Corporation
WAT
|
12.66 | $ 352.11 | 2.73 % | $ 21 B |